Restructuring and layoffs please use this new thread for updates

[anonymous]

Any word on what divisions and how they will be impacted?

 

[anonymous]

I heard infectious disease and neuro were told to stay home.

 

[anonymous]

in NS, all of ponvory got cut, schiz about 1/3 contract of contractors have been laid off in addition to internal overlays. no word on mood

 

[anonymous]

Some R&D scientists are finding out today… note clear of the scope yet.

 

[anonymous]

All of RSV medical and commercial were let go. Also, some in-house team of HIV were impacted

 

[anonymous]

in NS, all of ponvory got cut, schiz about 1/3 contract of contractors have been laid off in addition to internal overlays. no word on mood

The call wasn’t even until 4:30, dummy. Stop pretending you know ahead of time.

 

[anonymous]

At 5PM tonight, got invited to a 30 min. Immunology TA connect meeting scheduled for tomorrow. Budget has been tight and after Bill’s December video and recent email, who knows what’s going to happen here.

 

[anonymous]

I heard infectious disease and neuro were told to stay home.

What does this mean....?

 

[anonymous]

The call wasn’t even until 4:30, dummy. Stop pretending you know ahead of time.

Yet they were spot on.

 

[anonymous]

At 5PM tonight, got invited to a 30 min. Immunology TA connect meeting scheduled for tomorrow. Budget has been tight and after Bill’s December video and recent email, who knows what’s going to happen here.

What team within Immunology and how many calls do you have?

 

[anonymous]

What team within Immunology and how many calls do you have?

Derm is at 7am eastern

 

[James]

There are massive layoffs, but due to country specific rules, the impacted persons/departments are not yet informed. And then they say if you have concerns, discuss it with your manager. I'm a people manager and I'm not informed. So what am I going to say to my direct reports, when they are coming to me?
It was a bad Townhall.

 

[anonymous]

What does this mean....?

Neuro is gone.

 

[anonymous]

What do you mean? Neuro R&D?

 

[anonymous]

There are massive layoffs, but due to country specific rules, the impacted persons/departments are not yet informed. And then they say if you have concerns, discuss it with your manager. I'm a people manager and I'm not informed. So what am I going to say to my direct reports, when they are coming to me?
It was a bad Townhall.

 

[anonymous]

Seems like oncology and CVM R PH are scott free ?

 

[anonymous]

Seems like oncology and CVM R PH are scott free ?

Maybe CVMRPH has yet to announce?

 

[anonymous]

Seems like oncology and CVM R PH are scott free ?

Wrong, CVM is not off “scott free”
CVM just survived their massive headcount reduction in November 2022

 

[anonymous]

Reductions have been made in various parts of the org: RND, support functions and commercial. IDV, CVMRPH and Neuro commercial and RND have had the most changes from what I have seen. If your entire commercial/sales org has been gutted, the org sees limited near term sales contributions, from the internal pipeline or external possibilities. RND in those divisions better deliver and very quickly.
Oncology and Immunology have the best potential for delivering, both on the short and long term. Again, even they need to continue to actually deliver.
Since changes are occuring across the global organization, it will take some time to get a clear picture.
Every pharma company is facing a unique range of challenges, and how that plays out over the future will influence what additional changes are made at each company. Our areas include consumer spin out, exposure to litigation, actual booked sales and impact of LOE, the IRA in the US and reimbursement pressure in Europe, inflationary pressure.

 

[anonymous]

To whomever wrote the information above - thank you for being more transparent in one anonymous blog than in the countless townhall we have attended to date.